GLENMARK — Glenmark Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹628.43bn
- IN₹620.37bn
- IN₹169.83bn
Brief: Glenmark Pharmaceuticals Says USA Unit Agrees To $37.75 Million Settlement
India's Glenmark Pharma soars 10% to record high on AbbVie cancer licensing deal (updated)
Glenmark Pharma jumps on unit's cancer licensing deal with AbbVie
AbbVie rises after licensing deal for cancer treatment with India's Glenmark Pharma unit
India's Glenmark Pharma unit, Abbvie sign exclusive licensing pact (updated)
India's Glenmark Pharma unit, Abbvie sign exclusive licensing pact
Brief: Glenmark Pharma Says Ichnos Glenmark Innovation (IGI), Abbvie Announce Exclusive Global Licensing Agreement
India's Glenmark Pharma gains after cancer drug launch
Brief: Glenmark Pharma Says U.S. FDA Inspection At Co' Facility At Monroe
Brief: Glenmark Pharmaceuticals To Launch DCGI-Approved Zanubrutinib In India
India's Glenmark Pharma falls after co misses FY25 revenue forecast
Brief: Glenmark Pharmaceuticals Appoints Anurag Mantri As Executive Director And CFO
Brief: Glenmark Pharma Q4 Consol Net Profit 46.5 Million Rupees
India's Mankind Pharma beats profit estimates on demand for drugs to treat chronic illnesses
Indian pharma stocks climb on 'not as bad as feared' Trump order
Indian pharma stocks fall as Trump moves to cut U.S. drug prices (updated)
Indian pharma index bucks broader market gains on US tariff fears
Indian pharma stocks drop as Trump to sign executive order to cut prices of medicines
Brief: Glenmark Pharmaceuticals Says IGI Receives FDA Fast Track Designation For ISB 2001